Home NCDEX Emcure Pharma IPO lists at 31% premium on NSE NCDEX Emcure Pharma IPO lists at 31% premium on NSE By - July 10, 2024 29 0 FacebookTwitterPinterestWhatsApp Emcure IPO opened on July 3 and closed on July 5. It is a book-built issue valued at ₹1,952.03 crores. RELATED ARTICLESMORE FROM AUTHOR NCDEX Latest Business News, Live Updates Today July 21, 2024 NCDEX Lighter bags, heavier hearts: Home, restaurant kitchens feel pinch of vegetable price rise NCDEX Economic Survey to be tabled in Parliament today ahead of Budget: 10 points LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. - Advertisement - APPLICATIONS Odisha train accident: In new circular, railways calls for ‘double locking arrangements’ - June 5, 2023 Afternoon brief: BSF jawan killed, 2 Assam Rifles soldiers injured in Manipur, and all... - June 6, 2023 Avinash Reddy anticipatory bail plea: SC expresses displeasure over HC’s delay - May 23, 2023 Morning brief: US’ Nashville school shooter drew maps to plan massacre, and all the... - March 28, 2023 HOT NEWS Raghuram Rajan says Indian innovators have a ‘Virat Kohli mentality’: ‘Want... - April 17, 2024 0 NCDEX The former RBI governor said that India was not reaping the benefits of democratic dividend.